What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?

Bourdette, Dennis; Silbermann, Elizabeth

Bourdette, Dennis; Silbermann, Elizabeth.

Afiliação

Bourdette D; From the Department of Neurology (D.B., E.S.), Oregon Health & Science University; and Department of Veterans Affair Medical Center (E.S.), Portland, OR. bourdett@ohsu.edu.
Silbermann E; From the Department of Neurology (D.B., E.S.), Oregon Health & Science University; and Department of Veterans Affair Medical Center (E.S.), Portland, OR.

Neurology ; 101(20): 875-876, 2023 11 14.

Article em En | MEDLINE | ID: mdl-37852787

Assuntos

Vacinas contra COVID-19; COVID-19; Síndrome de Guillain-Barré; Humanos; COVID-19/prevenção & controle; Vacinas contra COVID-19/efeitos adversos; Síndrome de Guillain-Barré/epidemiologia; Síndrome de Guillain-Barré/etiologia; SARS-CoV-2; Vacinação/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Neurology Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google